May 24, 2007 NASD OTC-BB: MRDAF

Meridian Signs Contract for Exclusive Distribution of the LAPEX 2000 LipoLaser in Taiwan

Meridian Co., Ltd. ("Meridian" or the "Company") (OTC BB:MRDAF.OB - News), an industry leader in the research, development, manufacturing and sales of integrative medical equipment, is pleased to announce that it has signed a contract with Oliver Co., Ltd. ("Oliver") for exclusive marketing and distribution of Meridian's LAPEX 2000 LipoLaser in Taiwan.

The contract outlines that Oliver will be granted an exclusive license to market the LAPEX 2000 LipoLaser in Taiwan. Their exclusive distributorship for the LAPEX 2000 LipoLaser is based on a minimum order volume equal to sales of approximately US$750,000 for the initial 12-month period of the agreement. Under the terms of the agreement, Oliver has pre-paid US$100,000 to Meridian for the first portion of the initial purchase order.

Oliver is a Taiwanese medical equipment importer that distributes obesity management related products and equipment.

More About: LAPEX 2000 LipoLaser

The LAPEX 2000 LipoLaser was designed to target the medical and aesthetic market, specifically to address body shaping/contouring, spot fat reduction, and reduction in the appearance of cellulite. The LAPEX 2000 LipoLaser's non-invasive treatment is considered one of the most innovative methods to treat stubborn areas of fat that do not respond to diet and exercise. The demand for this type of treatment is expected to grow rapidly, not only in the plastic surgery profession but non-clinical settings such as spas and wellness centers that treat localized body fat deposits which may not have responded to diet and exercise.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing and sales of advanced medical devices in the healthcare industry. With a dynamic research and development team, Meridian is at the forefront in the development of cutting edge medical technologies. The Company presently holds a total of 18 worldwide patents on its technology, and has received approvals from the FDA and other international regulatory agencies, for many of its products. Meridian has over 1500 clients including physicians, hospitals, clinics, healthcare professionals, and wellness centers in North America, Asia, Europe, and Africa and continues to successfully market its superior product line to a growing number of clients worldwide.

On Behalf of the Board of Directors,

Hyeon Seong Myeong, President

This press release may contain certain forward-looking information and statements concerning the company's operations, performance and financial condition. These statements are based upon a number of uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. This document is not intended to be and is not an advertisement for any securities of the Company.

Contacts:
Meridian Co., Ltd.
Peter Holeczek
Corporate Communications
1-866-736-3306
Website: https://MeridianMedical.ca